Madelyn Rubenstein, Ms
About Madelyn Rubenstein, Ms
Madelyn Rubenstein is a Senior Manager of Alliance Leadership at Verge Genomics, where she has worked since 2023. She has extensive experience in the biotechnology industry, including roles at Alnylam Pharmaceuticals and Foundation Medicine, and teaches a Biotechnology Enterprise course at Northeastern University.
Work at Verge Genomics
Madelyn Rubenstein has been serving as the Senior Manager of Alliance Leadership at Verge Genomics since 2023. In this role, she is responsible for managing strategic partnerships and collaborations within the biotechnology sector. Her expertise in alliance leadership supports the company's mission to advance drug discovery and development through innovative approaches.
Education and Expertise
Madelyn Rubenstein holds a Master's degree in Biotechnology Enterprise from Northeastern University, which she completed from 2017 to 2019. She also earned a Bachelor of Science in Neuroscience from the University of Rochester between 2011 and 2015. Additionally, she has a background in Liberal Arts and Sciences from McDonogh School. Her education provides a strong foundation for her work in biotechnology and drug development.
Professional Background
Madelyn Rubenstein has a diverse professional background in the biotechnology industry. She began her career as a Research Assistant at Boston Children's Hospital from 2015 to 2017. She has held various roles, including Clinical Trial Associate and Intern at Alnylam Pharmaceuticals, Associate Project Manager at Foundation Medicine, and Coordinator of Research Operations at Sage Therapeutics. Her experience spans clinical operations, project management, and research.
Teaching and Mentorship
Madelyn Rubenstein has been a Part-Time Lecturer at Northeastern University since 2022, where she teaches a Biotechnology Enterprise course for graduate students. She is passionate about mentoring biotechnology students, guiding them in co-op opportunities, internships, and career paths. Her involvement in academia reflects her commitment to fostering the next generation of professionals in the biotechnology field.
Achievements in Biotechnology
Throughout her career, Madelyn Rubenstein has developed a strong understanding of the drug development process, including clinical development and companion diagnostics. Her roles in various organizations have equipped her with experience in R&D operations and partnership management. This expertise contributes to her effectiveness in her current position at Verge Genomics and her teaching role at Northeastern University.